Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Hematology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00277-012-1539-6PMID 22869090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• De Novo Daptomycin-Nonsusceptible Enterococcal Infections

  2012cited by this paper
• Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution

  2011cited by this paper
• Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.

  2011cited by this paper
• Genetic Basis for Daptomycin Resistance in Enterococci

  2011cited by this paper
• Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).

  2009cited by this paper
• Optimizing therapy for vancomycin-resistant enterococci (VRE).

  2007cited by this paper
• Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

  2007cited by this paper
• Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.

  2006cited by this paper
• Resistance Studies with Daptomycin

  2001cited by this paper

• Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility

  2022cites this paper
• Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms.

  2021cites this paper
• Antibiotic Consideration in Transplant Recipients

  2019cites this paper
• Staphylococcus, Streptococcus, and Enterococcus

  2019cites this paper
• Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.

  2019cites this paper
• Principles and Practice of Transplant Infectious Diseases

  2019influential citation
• Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen

  2018cites this paper
• Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes

  2017cites this paper
• Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy

  2016cites this paper
• Tedizolid Phosphate: a Next-Generation Oxazolidinone

  2015cites this paper
• Vancomycin-Resistant Enterococcal Bacteremia Pharmacotherapy

  2015cites this paper
• Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.

  2015cites this paper
• Epidemiology of Infections in Cancer Patients

  2014cites this paper
• The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients

  2014cites this paper